Registration Dossier

Administrative data

Description of key information

Key value for chemical safety assessment

Repeated dose toxicity: via oral route - systemic effects

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed
Dose descriptor:
NOAEL
839.6 mg/kg bw/day

Repeated dose toxicity: inhalation - systemic effects

Endpoint conclusion
Endpoint conclusion:
no study available

Repeated dose toxicity: inhalation - local effects

Endpoint conclusion
Endpoint conclusion:
no study available

Repeated dose toxicity: dermal - systemic effects

Endpoint conclusion
Endpoint conclusion:
no study available

Repeated dose toxicity: dermal - local effects

Endpoint conclusion
Endpoint conclusion:
no study available

Additional information

A well documented 13 week subchronic toxicity study is available for the structurally related 2-octyldodecan-1-ol (C20). Male and female rats received the sustance daily by gavage. There were no indications that 2-octyldodecan-1-ol was toxic at the limit dose of 1 ml/kg bw/d. Due to their structural similarity no effects are expected after repeated oral application of the other Guerbet alcohols of this category either.

Additional data are available for the linear C22-alcohol docosan-1-ol. In a repeated dose toxicity study conducted according to a Guideline similar to OECD Guideline 408 male and female rats received oral doses of up to 1000 mg/kg daily for 26 weeks. No effects were observed resulting in a NOEL of 1000 mg/kg bw.

Justification for classification or non-classification

Available data are conclusive but not sufficient for classfication of 2 -hexyldecan-1 -ol with regard to repeated dose toxicity.